Bromocriptine, methyl testosterone and placebo for inhibition of physiological lactation. A controlled study

Biggs J.S.G., Hacker N., Andrews E. and Munro C. (1979) Bromocriptine, methyl testosterone and placebo for inhibition of physiological lactation. A controlled study. Medical Journal of Australia, 2 Suppl. 3: 23-25.

Author Biggs J.S.G.
Hacker N.
Andrews E.
Munro C.
Title Bromocriptine, methyl testosterone and placebo for inhibition of physiological lactation. A controlled study
Journal name Medical Journal of Australia   Check publisher's open access policy
ISSN 0025-729X
Publication date 1979-01-01
Sub-type Article (original research)
Open Access Status Not yet assessed
Volume 2
Issue Suppl. 3
Start page 23
End page 25
Total pages 3
Language eng
Subject 2700 Medicine
Abstract Lactation occurs when the fully developed breast is released from the inhibitory influence which oestrogen and progesterone exert upon the action of prolactin. The use of oestrogens to suppress lactation depends on a continuation of the peripheral, that is, mammary, inhibition of prolactin. Androgens are also believed to act by inhibition of the action of prolactin on the mammary gland epithelium. Bromocriptine, when compared in a double-blind trial with orally administered methyl testosterone and placebo, gave almost complete relief of breast discomfort and congestion, though a small amount of milk production was seen. Methyl testosterone, in the dosage used in this study, was quite ineffective in suppressing lactation or breast symptoms.
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: Scopus Import - Archived
 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 14 Jun 2016, 12:20:32 EST by System User